
The FDA announced on Wednesday that it approved Bristol-Myers Squibb’s Opdivo in combination with Yervoy to treat patients with hepatocellular …
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

